Reprogramming resistance in advanced lung cancer: epigenetic modulation to restore therapeutic vulnerability
{{output}}
Lung cancer is the most prevalent cancer and cause of death; most patients present themselves at an advanced stage and continuously acquire resistance to targeted agents, antibody-drug conjugates, chemotherapy, and immune checkpoint inhibitors. In addition to ... ...